Companies / Moleculin Biotech, Inc.

Moleculin Biotech, Inc.

Nasdaq: MBRXCIK 1659617HOUSTON, TX

Financials · FY2025

Revenue$0
Net income$-33.56M
Total debt
Cash$7.26M
Diluted EPS
Shares outstanding5.3M

Ownership

5.3M shares outstanding · as of May 7, 2026
0.01%Insiders
Ownership
Insiders0.01%753
Institutions2.11%112,407
Public float97.88%5,223,190

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Picker Donald HChief Science Officer
0.01%753

Institutional holders 17

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 22, 2026Picker Donald H
Executive
OtherCommon Stock$66-21
-2.71%
753
0.01% of shares
low
Jun 20, 2026Picker Donald H
Executive
OtherCommon Stock$37-13
-1.82%
703
0.01% of shares
low
Jun 22, 2026Picker Donald H
Executive
ExerciseRestricted Stock Units-71
-0.36%
19,596
0.37% of shares
low
Jun 20, 2026Picker Donald H
Executive
ExerciseRestricted Stock Units-44
-0.22%
19,667
0.37% of shares
low
Jun 22, 2026Picker Donald H
Executive
ExerciseCommon Stock+71
+10.10%
774
0.01% of shares
low
Jun 20, 2026Picker Donald H
Executive
ExerciseCommon Stock+44
+6.55%
716
0.01% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MBRXCommon StockEquity60855D408BBG00B9T47L9